AngioDynamics Announces Availability of the AquaLiner Hydrophilic Guidewire in the United States.Business Editors/Health/Medical Writers QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 15, 2003 AngioDynamics, Inc., a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of E-Z-EM, Inc., (AMEX AMEX See: American Stock Exchange : EZM) today announced the release for sale of the AquaLiner(TM) hydrophilic hydrophilic /hy·dro·phil·ic/ (-fil´ik) readily absorbing moisture; hygroscopic; having strongly polar groups that readily interact with water. hy·dro·phil·ic adj. Ni-Ti alloy guidewire in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . The AquaLiner hydrophilic guidewire has a hydrophilic coating, which helps reduce friction when the guidewire comes into contact with fluids. This innovative feature allows a physician to move the guidewire through vessels and catheters with greater ease, simplifying guidewire placement in endovascular procedures. With today's announcement, customers can now purchase AquaLiner hydrophilic guidewires through the AngioDynamics direct sales force. AngioDynamics previously announced its exclusive distribution agreement with Nipro Medical Corporation for the AquaLiner hydrophilic guidewire. Nipro Medical Corporation--a wholly owned subsidiary of Nipro Corporation of Osaka, Japan (Tokyo Premium Exchange: Nipro - 8086)--is a leading manufacturer and research developer of innovative medical technology. Commenting for AngioDynamics, Michelle Mechaley, Director for Angiographic Products said, "The AquaLiner hydrophilic guidewire offers next generation performance through its superior design and coating endurance, providing the hydrophilic longevity that minimally invasive procedures demand. We are pleased to be bringing this important product to interventional radiologists in the United States." For additional information on the AquaLiner hydrophilic Ni-Ti alloy guidewire, contact Michelle Mechaley at 1-800-772-6446, ext. 341, Email: mmechaley@angiodynamics.com or visit the AngioDynamics web site at www.angiodynamics.com. About E-Z-EM E-Z-EM, Inc. (www.ezem.com) is a leading supplier of products used by radiologists, gastroenterologists and speech language pathologists for the diagnostic imaging of diseases and disorders of the GI tract, ranging from swallowing disorders Swallowing Disorders Definition Swallowing disorders include a number of diseases and conditions that cause difficulty in passing food or liquid from the mouth to the stomach. (dysphagia dysphagia /dys·pha·gia/ (-fa´jah) difficulty in swallowing. dys·pha·gia or dys·pha·gy n. Difficulty in swallowing or inability to swallow. ) to colorectal cancers. E-Z-EM also is a third-party contract manufacturer of diagnostic contrast media, pharmaceuticals, non-prescription healthcare products, and defense decontaminants. About Nipro Medical Corporation Nipro Medical Corporation (www.nipro.com) is a fully owned subsidiary of Nipro Corporation (www.nipro.co.jp) of Osaka, Japan. Nipro Medical Corporation imports and distributes in the Americas the medical and disposable devices manufactured by its parent company in Japan. For additional information on Nipro Medical Corporation, please contact Philip Stocton, National Sales Manager, at 1-888-647-7698, ext. 239, Email: phils@nipromed.com or visit the Nipro web site at www.nipro.com. About AngioDynamics AngioDynamics, Inc. (www.angiodynamics.com) is a leading supplier of products used by interventional radiologists and other physicians for the minimally invasive diagnosis and therapeutic treatment of peripheral vascular disease Peripheral Vascular Disease Definition Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms. . The statements made in this document contain certain forward-looking statements that involve a number of risks and uncertainties. Words such as "expects", "intends", "anticipates", "plans", "believes", "seeks", "estimates," or variations of such words and similar expressions, are intended to identify such forward-looking statements. Investors are cautioned that actual events or results may differ from the Company's expectations. In addition to the matters described above, the ability of the Company to develop its products, future actions by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from Group Purchasing Organizations, competition, including alternative procedures which continue to replace traditional fluoroscopic Fluoroscopic (fluoroscopy) An x-ray procedure that produces immediate images and motion on a screen. The images look like those seen at airport baggage security stations. Mentioned in: Hypotonic Duodenography procedures, as well as the risk factors listed from time to time in the SEC filings of E-Z-EM, Inc., including but not limited to its Form 10-Q Form 10-Q See 10-Q. for the quarter ended August 31, 2002, as well as its Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended May 31, 2003, may affect the actual results achieved by the Company. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion